COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs-Reference-Cited by-同舟云学术

COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs

Published:2021-01 Issue: Volume:8 Page:204993612110270
ISSN:2049-9361
Container-title:Therapeutic Advances in Infectious Disease
language:en
Short-container-title:Therapeutic Advances in Infection

Author:

Rodriguez-Morales Alfonso J.¹²³^ORCID,Sah Ranjit⁴,Millan-Oñate Jose⁵,Gonzalez Angel⁶,Montenegro-Idrogo Juan J.³⁷,Scherger Sias⁸,Franco-Paredes Carlos⁸^ORCID,Henao-Martínez Andrés F.⁸⁹^ORCID

Affiliation:

1. Grupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de las Américas, Belmonte, Pereira, Risaralda 660003, Colombia. Associate Editor, Therapeutic Advances in Infectious Disease

2. Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19), Pereira, Risaralda, Colombia

3. Clinical Epidemiology and Biostatistics, Universidad Científica del Sur, Lima, Peru

4. Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal

5. Adult Infectious Diseases, Clínica Imbanaco QuirónSalud, Cali, Valle del Cauca, Colombia

6. Basic and Applied Microbiology Research Group (MICROBA), School of Microbiology, Universidad de Antioquia, Medellin, Colombia

7. Service of Infectious and Tropical Diseases, Hospital Nacional Dos de Mayo, Lima, Perú

8. Division of Infectious Diseases, University of Colorado Denver School of Medicine, Anschutz Medical Campus, Aurora, CO, USA

9. Editor in Chief, Therapeutic Advances in Infectious Disease

Publisher

SAGE Publications

Subject

Pharmacology (medical),Infectious Diseases

Link

http://journals.sagepub.com/doi/pdf/10.1177/20499361211027065

Reference58 articles.

1. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study

2. Lymphopenia during the COVID-19 infection: What it shows and what can be learned

3. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis

4. A review of the main histopathological findings in coronavirus disease 2019

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Safety and Effectiveness of Antifungal Medications in the Management of Mucormycosis during the COVID-19 Pandemic;Current Drug Safety;2024-02

2. Development of a monoclonal antibody and a lateral-flow device for the rapid detection of a Mucorales-specific biomarker;Frontiers in Cellular and Infection Microbiology;2023-12-08

3. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran;Mycopathologia;2023-09-06

4. Outcome of Total Surgical Debridement of Covid Associated Rhino-Orbito-Cerebral Mucormycosis Based on a New Surgical Staging System: A Cohort Study;Indian Journal of Otolaryngology and Head & Neck Surgery;2023-08-29

5. DIAGNOSIS AND TREATMENT OF MUCORMYCOSIS: AN INTRUDER POST-COVID-19;Asian Journal of Pharmaceutical and Clinical Research;2023-08-07